Articles related to WOMEN'S HEALTH

In a recent study, researchers discovered that all women who consumed one or more SSBs daily had an OCC risk 4.87 times higher than those consuming less than one SSB per month.

This innovative intrauterine device may allow for improvements in discontinuation rates due to pain and bleeding and in expulsion rates.

A comprehensive analysis of 176,601 cancer cases demonstrates that long-acting reversible contraceptives offer a cancer risk profile comparable to oral contraceptives, with data showing a 20-30% reduction in gynecologic cancer risk and a modest increase in breast cancer risk that returns to baseline after cessation.

Medical bias can lead to missed diagnoses when physicians default to weight-related assumptions rather than conducting comprehensive evaluations.

Early detection of endometrial cancer through proper evaluation of postmenopausal bleeding can dramatically impact survival rates, with early-stage diagnosis offering significantly better outcomes.

Long-acting reversible contraceptives show varying effects on cancer risk, with some methods demonstrating protective effects against certain cancers while increasing risks for others.